BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1060 related articles for article (PubMed ID: 19584707)

  • 21. Response of retinoic acid-resistant KG1 cells to combination of retinoic acid with diverse histone deacetylase inhibitors.
    Savickiene J; Treigyte G; Magnusson KE; Navakauskiene R
    Ann N Y Acad Sci; 2009 Aug; 1171():321-33. PubMed ID: 19723072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac histones are substrates of histone deacetylase activity in hemorrhagic shock and resuscitation.
    Lin T; Alam HB; Chen H; Britten-Webb J; Rhee P; Kirkpatrick J; Koustova E
    Surgery; 2006 Mar; 139(3):365-76. PubMed ID: 16546502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation.
    Park JH; Jung Y; Kim TY; Kim SG; Jong HS; Lee JW; Kim DK; Lee JS; Kim NK; Kim TY; Bang YJ
    Clin Cancer Res; 2004 Aug; 10(15):5271-81. PubMed ID: 15297431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the histone deacetylase inhibitor trichostatin a in human peripheral blood lymphocytes as a function of donor age.
    Sourlingas TG; Kypreou KP; Topakas GN; Karchilaki IN; Stavropoulos-Giokas C; Sekeri-Pataryas KE
    Ann N Y Acad Sci; 2007 Nov; 1119():64-71. PubMed ID: 18056955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experiment study of PHI on histone methylation and acetylation in Molt-4 cells].
    Huang YQ; Ma XD; Zhen RJ; Chiao JW; Liu DL
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):612-5. PubMed ID: 18246819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.
    Ishihara K; Hong J; Zee O; Ohuchi K
    Br J Pharmacol; 2004 Jul; 142(6):1020-30. PubMed ID: 15210580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth inhibitory and differentiation effects of chloroquine and its analogue on human leukemic cells potentiate fetal hemoglobin production by targeting the polyamine pathway.
    Iyamu E; Perdew H; Woods G
    Biochem Pharmacol; 2009 Mar; 77(6):1021-8. PubMed ID: 19073155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxorubicin induces apoptosis with profile of large-scale DNA fragmentation and without DNA ladder in anaplastic thyroid carcinoma cells via histone hyperacetylation.
    Rho JH; Kang DY; Park KJ; Choi HJ; Lee HS; Yee SB; Yoo YH
    Int J Oncol; 2005 Aug; 27(2):465-71. PubMed ID: 16010429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copper induces histone hypoacetylation through directly inhibiting histone acetyltransferase activity.
    Kang J; Lin C; Chen J; Liu Q
    Chem Biol Interact; 2004 Jul; 148(3):115-23. PubMed ID: 15276868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors.
    Ishihara K; Takahashi A; Kaneko M; Sugeno H; Hirasawa N; Hong J; Zee O; Ohuchi K
    Life Sci; 2007 Mar; 80(13):1213-20. PubMed ID: 17258775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of apicidin, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H; Im JY; Kim J; Choi WS; Kim HS
    Int J Mol Med; 2008 Mar; 21(3):325-33. PubMed ID: 18288380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deregulation of polyamine biosynthesis alters intrinsic histone acetyltransferase and deacetylase activities in murine skin and tumors.
    Hobbs CA; Paul BA; Gilmour SK
    Cancer Res; 2002 Jan; 62(1):67-74. PubMed ID: 11782361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells.
    Attoub S; Hassan AH; Vanhoecke B; Iratni R; Takahashi T; Gaben AM; Bracke M; Awad S; John A; Kamalboor HA; Al Sultan MA; Arafat K; Gespach C; Petroianu G
    Eur J Pharmacol; 2011 Jan; 651(1-3):18-25. PubMed ID: 21074525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells.
    Lee KW; Kim JH; Park JH; Kim HP; Song SH; Kim SG; Kim TY; Jong HS; Jung KH; Im SA; Kim TY; Kim NK; Bang YJ
    Anticancer Res; 2006; 26(5A):3429-38. PubMed ID: 17094463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
    Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylase inhibitors induce growth inhibition, cell cycle arrest and apoptosis in human choriocarcinoma cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2008 Jan; 21(1):109-15. PubMed ID: 18097623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
    Wang Q; Yang W; Uytingco MS; Christakos S; Wieder R
    Cancer Res; 2000 Apr; 60(7):2040-8. PubMed ID: 10766196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential sensitivity of human leukemic cell lines to the histone deacetylase inhibitor, trichostatin A.
    Ninios YP; Sekeri-Pataryas KE; Sourlingas TG
    Leuk Res; 2010 Jun; 34(6):786-92. PubMed ID: 19782399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2006 Feb; 17(2):323-9. PubMed ID: 16391833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential modulation of nuclear texture, histone acetylation, and MDR1 gene expression in human drug-sensitive and -resistant OV1 cell lines.
    Yatouji S; El-Khoury V; Trentesaux C; Trussardi-Regnier A; Benabid R; Bontems F; Dufer J
    Int J Oncol; 2007 Apr; 30(4):1003-9. PubMed ID: 17332941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.